Última Hora: "La OPI de Facebook valora la compañía en 82.090 millones de euros - elEconomista.es" Fri, 18 May 2012 08:10:25 GMT    "El consumo público y la inversión aceleran la caída de la actividad - Cinco Días" Thu, 17 May 2012 23:04:46 GMT    "La CEOE considera necesario plantear una nueva reforma de las ... - Información" Fri, 18 May 2012 03:12:53 GMT    "La prima de riesgo abre al alza y supera los 490 puntos tras el ... - El Periódico de Catalunya" Fri, 18 May 2012 07:09:55 GMT    "La CE descarta el rescate a España y ve positivo el acuerdo con ... - RTVE" Fri, 18 May 2012 09:17:35 GMT    "La morosidad en la banca subió al 8,36% en el primer trimestre de 2012 - La Vanguardia" Fri, 18 May 2012 08:45:49 GMT    "ArcelorMittal vende una distribuidora de acero americana por 478 ... - ABC.es" Fri, 18 May 2012 09:32:47 GMT    "Aprobado para el Plan de la Generalitat - Expansión.com" Fri, 18 May 2012 08:38:42 GMT   "El 'efecto Goiri': Bankia se dispara más de un 30% tras diez días ... - Cotizalia.com" Fri, 18 May 2012 09:14:45 GMT    "La banca resiste en el Ibex la rebaja de Moody's - El Periódico de Catalunya" Fri, 18 May 2012 07:54:50 GMT      Para más noticias, haga clic aquí.

Zona de Acceso
       
       
¿Recordarme? 

Busque más análisis técnicos aquí en nuestro foro: Análisis Técnicos
Nota: Los datos después de 2012-05-17 son temporales y pueden tener un valor de Apertura incorrecto hasta nueva actualización...
Cambiar para Gráfico Estático de Amylin Pharmaceut

Sin variación
Amylin Pharmaceut - [Ticker: AMLN]Gráfico Amylin Pharmaceut  Noticias Amylin Pharmaceut  Descargar Históricos de Metastock Amylin Pharmaceut y Otros  Análisis Técnico Amylin Pharmaceut  
Última Transacción27,210Hora de Cotización2012-05-17 - 21:00
Variación0,000 (0,000%)Rango 52 Semanas[8,030 - 28,020]
Máximo0,000Mínimo0,000
Volumen259Volumen Medio (3m)4.152.360
Demanda / Oferta27,170 x 400 - 27,500 x 500YieldN/A
Cierre Anterior27,210PER0,00%
Apertura0,000EPS-4,11
Fecha Ex-DividendoN/AFecha DividendoN/A
Capitalización Bursátil4 Objetivo Estimado 1 Año20,630
Nota: Los datos pueden tener un retraso de algunos minutos.

 Noticias de Amylin Pharmaceut [AMLN]:   (ordenadas por relevancia)

Our Take: CSOD, VOXX, FSLR, VRX Among Charts to Watch
The Mumbai Times
Amylin Pharmaceuticals Inc (NASDAQ:AMLN) shares were trading at $27.30 while reporting up 6.43% from yesterdays close. The 13 analysts offering 12-month price forecasts for Amylin Pharmaceuticals Inc have a median target of 22.00, with a high estimate ...


XBI, HGSI, AMLN, INCY: ETF Inflow Alert
Forbes
Among the largest underlying components of XBI, in trading today Human Genome Sciences Inc. (NASD: HGSI) is up about 0.5%, Amylin Pharmaceuticals, Inc. (NASD: AMLN) is off about 0.8%, and Incyte Corporation (NASD: INCY) is lower by about 2.5%.


Amylin Said to Attract Interest From Pfizer, AstraZeneca
BusinessWeek
By Jeffrey McCracken, Albertina Torsoli and Meg Tirrell on May 15, 2012 Amylin Pharmaceuticals Inc. (AMLN) (AMLN) has lured suitors such as Pfizer Inc. (PFE) (PFE), AstraZeneca Plc (AZN) and Sanofi, which signed confidentiality agreements on the ...

y más »

LEN, AMLN, ARIA, TRIP, KMB Hit New 52-Week Highs
Fyxnews
Amylin Pharmaceuticals (NASDAQ:AMLN) hit a new 52 week high of $28.02 in intraday trading and closed at $27.54 +0.88% on 4912042 shares traded. Amylin Pharmaceuticals, Inc. is a biopharmaceutical company, which is engaged in the discovery, ...
DHI, DFG, LEN, AMLN, DF Hit New 52-Week HighsThe Mumbai Times

los 2 artículos informativos »

Bloomberg

Amylin Goes A Little Wizard Of Oz On Shareholders
Seeking Alpha
For a company that owes about 45% of its post-March 28 market cap to buyout rumors, biopharma Amylin Pharmaceuticals (AMLN) continues to be stubbornly silent on the question of whether or not the company is for sale, at what price, and potentially to ...
Big-name pharmas peer at Amylin's books to prep for bidsFiercePharma
Buzz: Big Pharma suitors line up for a look at Amylin's booksFierceBiotech
3 Dow Movers with News You Must KnowWall St. Cheat Sheet

los 20 artículos informativos »

Bloomberg

This Biotech's for Sale! Reportedly.
DailyFinance
By Brian Orelli, The Motley Fool Amylin Pharmaceuticals (NAS: AMLN) investors are giddy today after Bloomberg reported a laundry list of potential suitors for the biotech. You'll recall the same publication said Bristol-Myers Squibb (NYS: BMY) ...
Amylin (AMLN) Attracting a Host of Other Suitors, Shares RiseStreetInsider.com (subscription)
Amylin said to be attracting several Big Pharma suitorsThe Pharma Letter

los 11 artículos informativos »

Investorplace.com

Colgate-Palmolive, Amylin Pharmaceuticals, Other Stocks Hit 52-Week Highs Tuesday
Fox Business
The share price of Amylin Pharmaceuticals (AMLN) climbed today, reaching and then surpassing its previous 52-week high of $26.87. The stock was trading on above-average volume. The stock price has gained 6.4% with 5.4 million shares moving.
Highs & Lows: Amylin Pharmaceuticals, Colgate-Palmolive, and EricssonSchaeffers Research (blog)

los 14 artículos informativos »

Amylin Said to Attract Interest From Pfizer, AstraZeneca
Bloomberg
Deals Amylin Said to Attract Pfizer, AstraZeneca, Sanofi in Sale Amylin Pharmaceuticals Inc. (AMLN) has lured suitors such as Pfizer Inc., AstraZeneca Plc and Sanofi (SAN), which signed confidentiality agreements on the drugmaker's sale process, ...

y más »

Amylin Pharmaceuticals (AMLN) - Daily Volume Update
AVAFIN
Shares of Amylin Pharmaceuticals rose $1.65 (+6.43%) to $27.30 in today's trading session. The price of AMLN ranged between $26.65 - $27.40. Volume is 8M in relation to the three month average volume of 4M shares. AMLN is trading above the 50 day ...


Bloomberg

Amylin Said to Seek Buyers After Rejecting Bristol-Myers
Bloomberg
Amylin Pharmaceuticals Inc. (AMLN), the maker of the diabetes drugs Bydureon and Byetta, is seeking a buyer after rejecting an unsolicited bid from Bristol-Myers Squibb Co. (BMY), two people with knowledge of the matter said. Amylin has hired Credit ...
Amylin Pharmaceuticals Reports First Quarter 2012 Financial ResultsMarketWatch (press release)
Icahn: Suit Against Amylin Dropped After Talks With CEOWall Street Journal
Judge fast-tracks Icahn lawsuit against AmylinReuters

los 72 artículos informativos »

Amylin climbs 6% on buyout speculation
MarketWatch
BOSTON (MarketWatch) -- Shares of Amylin Pharmaceuticals (US:amln) climbed 6% in early trading Tuesday after analysts at Leerink Swann said they see Sanofi (US:sny) and Merck (US:mrk) emerging as the strongest bidders for the biotech firm, ...


Bloomberg

Exclusive: Amylin explores sale, hires bankers: sources
Reuters
By Paritosh Bansal and Soyoung Kim | NEW YORK (Reuters) - Amylin Pharmaceuticals Inc (AMLN.O), which spurned a $3.5 billion takeover bid from Bristol-Myers Squibb Co (BMY.N) and is fending off a lawsuit from activist investor Carl Icahn, ...
Buzz: Amylin brings in the bankers to spur an auctionFierceBiotech
Reports: Amylin Seeks BuyersRTT News
Why Amylin Shares PoppedDailyFinance
Investor's Business Daily -Benzinga
los 53 artículos informativos »

Lilly, Jaguar Land Rover, Viacom: Intellectual Property
BusinessWeek
The drugmaker is interested in buying San Diego-based Amylin Pharmaceuticals Inc. (AMLN) (AMLN) and its diabetes drugs Bydureon and Byetta, which generated more than $650 million in revenue last year, Bloomberg reported on May 15.

y más »

Amylin Pharmaceuticals to Present at Annual Meeting of Stockholders
MarketWatch (press release)
SAN DIEGO, May 08, 2012 (BUSINESS WIRE) -- Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN) will webcast its Annual Meeting of Stockholders on Tuesday, May 15, 2012 at 9:00 am PT/ 12:00 pm ET from the Company's corporate headquarters in San Diego.
AMYLIN PHARMACEUTICALS, INC. : Amylin Pharmaceuticals to Present at Annual ...4-traders

los 6 artículos informativos »

Tuesday's biggest gaining and declining stocks
MarketWatch
Amylin Pharmaceuticals Inc. (US:AMLN) shares tacked on 6%. The company said in a filing late Monday that one of its directors had bought 18000 shares of the firm's stock. Dick's Sporting Goods (US:DKS) rose 6% after the retailer reported a 53% jump in ...

y más »
Para más noticias de Amylin Pharmaceut hacer clic aquí:
Noticias de Amylin Pharmaceut 


Anchura de la Página:

 Imagen de Fondo:

Copyright@2009-2012 - BolsaES.com, todos los derechos reservados.
Foro de Bolsa Cotizaciones Noticias de Bolsa Chat de Bolsa Disclaimer Recursos para Webmasters